Company / R&D per Share
Inmune Bio, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.49
FY2025
5-year range
$0.44 / $1.49
FY2021-FY2025
Trend
+31.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.95 to $1.49 over the past 2 years.
Based on SEC 10-K filings.
1.49 in FY2025 with a 5-year CAGR of +37.3%.
Improved from $0.95 to $1.49 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +37.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 31.8% year-over-year.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.49 | +31.8% |
| FY2024 | $1.13 | +18.8% |
| FY2023 | $0.95 | -17.4% |
| FY2022 | $1.15 | +162.3% |
| FY2021 | $0.44 | +44.1% |
| FY2020 | $0.30 | +482.3% |
| FY2018 | $0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026